Shunho Stock Confirms Patent Authorization for Synthetic Nicotine Composition

Regulations by 2FIRSTS.ai

May.08.2024

Shunho Stock Confirms Patent Authorization for Synthetic Nicotine Composition

Shunho shares confirm subsidiary Yunnan Xike's patent approval for synthetic nicotine composition in the US for medical business expansion.

On May 6th, an investor asked a question to Shunho shares (003565) on the interactive platform, "It is rumored that the company's shareholding company Yunnan Xike has been granted authorization for the patent 'Synthetic Nicotine Composition' in the United States. This patented technology will be used to expand into the biopharmaceutical sector. Can you confirm this? Does the company or its subsidiaries have any other strategic plans in the field of synthetic biology?

Shunho Corporation stated that its affiliated company, Yunnan Xike Technology Co., Ltd., was granted the invention patent "Synthetic Nicotine Composition" in August 2021, and this patent is still valid. The synthetic nicotine composition covered by this patent technology has the advantages of safety, stability, and ease of storage. It can be used in various fields such as low-temperature HNB products, e-cigarettes, nicotine release patches, pharmaceutical synthesis, etc.

References:

[1] 顺灏股份问答

Also Read:

[1] Shunho 2023 Annual Performance: Revenue Increase and Yilong Brand Expansion

[2] Shunho Group: Cooperation with China Tobacco Subsidiaries on HNB

[3] Shunhao Shares Response to Legalization of Cannabis in Europe

#E-liquids #Asia #Market #China #Technology.#Products #Heated tobacco products #Synthetic Nicotine Composition

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches

CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.

Nov.04

China’s E-Cigarette Exports Reached USD 879 Million in September 2025, Down 6.08% MoM— U.S. Remains Top Market, Russia Falls Sharply

In September 2025, China’s total e-cigarette exports reached USD 879 million, representing a 6.08% decline month-on-month but a 3.41% increase year-on-year.

Oct.20 by 2FIRSTS.ai

Ukrainian Researchers Estimate E-Cigarette Black Market at 90%, Warn of About $180 Million Budget Hit in 2025

Ukrainian researchers estimate that the illicit e-cigarette market makes up about 93% of total sales. Based on the National Bank of Ukraine’s exchange rate, if the black market remains at its current size, Ukraine’s state and local budgets could lose roughly $180 million in revenue in 2025.

Oct.16 by 2FIRSTS.ai

Singapore Charges 14 Over Vape Syndicate Under Organised Crime Act

Singapore police said 13 people were charged on Oct 30 under the Organised Crime Act over an alleged syndicate supplying vapes locally; a 14th suspect is expected to be charged on Oct 31. All 14 had earlier been charged for possessing, or conspiring to possess, vapes for sale and are remanded. Police said the group allegedly imported vapes from Malaysia. OCA carries up to S$100,000 fine or five years’ jail; vape import/sale offences also face stiff penalties.